title: Effects of restricted feeding on the activity of hypothalamic Orexin (OX)-A containing neurons and OX2 receptor mRNA level in the paraventricular nucleus of rats.
abstract: We have examined the effects of 3 weeks of food restriction on both the activity of neurons containing hypothalamic orexin (OX)-A and the level of OX receptor type 2 (OX2R) mRNA in the paraventricular nucleus (PVN) of rats. Double immunohistochemistry was used to examine the expression of OX-A and Fos in the lateral hypothalamic area (LHA), and in situ hybridization histochemistry was used to measure levels of OX2R mRNA in the PVN. After the period of restricted feeding, 20-30% of OX-A-containing neurons exhibited Fos-like immunoreactivity (LI). The distribution of OX-A-LI/Fos-LI cells in the food-restricted rats was similar to that observed in glucose-deprived rats after intracerebroventricular (icv) administration of 2-deoxy-D-glucose (2-DG). In addition, 3 weeks of food restriction caused a significant decrease in the expression of the OX2R gene in the parvocellular division of the PVN. These results suggest that the activation of OX-A-containing neurons induced by restricted feeding may be involved in neuroendocrine responses to food restriction.
authors.affiliation: Department of Mental Health, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, 807-8555, Kitakyushu, Japan.
authors.forename: Tatsuhiko
authors.initials: T
authors.lastname: Kurose
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Ueta
authors.forename: Yukiyo
authors.initials: Y
authors.lastname: Yamamoto
authors.forename: Ryota
authors.initials: R
authors.lastname: Serino
authors.forename: Yumi
authors.initials: Y
authors.lastname: Ozaki
authors.forename: Jun
authors.initials: J
authors.lastname: Saito
authors.forename: Shoji
authors.initials: S
authors.lastname: Nagata
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Yamashita
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight / Q000502:physiology; D002352:Carrier Proteins / Q000096:biosynthesis* / Q000502:physiology; D004435:Eating / Q000502:physiology*; D007026:Hypothalamic Area, Lateral / Q000378:metabolism / Q000502:physiology; D007150:Immunohistochemistry / Q000379:methods; D017403:In Situ Hybridization / Q000379:methods; D047908:Intracellular Signaling Peptides and Proteins; D008297:Male; D009474:Neurons / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D009479:Neuropeptides / Q000096:biosynthesis* / Q000502:physiology; D064446:Orexin Receptors; D000068797:Orexins; D009994:Osmolar Concentration; D010286:Paraventricular Hypothalamic Nucleus / Q000502:physiology*; D016760:Proto-Oncogene Proteins c-fos / Q000096:biosynthesis / Q000502:physiology; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D017208:Rats, Wistar; D043562:Receptors, G-Protein-Coupled; D018013:Receptors, Neuropeptide / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism; D012964:Sodium / Q000097:blood
chemical_list: D001786:Blood Glucose; D002352:Carrier Proteins; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D064446:Orexin Receptors; D000068797:Orexins; D016760:Proto-Oncogene Proteins c-fos; D012333:RNA, Messenger; D043562:Receptors, G-Protein-Coupled; D018013:Receptors, Neuropeptide; D012964:Sodium